Neha Krishnamohan Arcutis Biotherapeutics, Inc. (ARQT) insider trading activity

Neha Krishnamohan is Director of Arcutis Biotherapeutics, Inc.. Currently has a direct ownership of 22,123 shares of ARQT, which is worth approximately $553,075. The most recent transaction as insider was on Nov 13, 2025, when has been sold 40,504 shares (Common Stock) at a price of $23.28 per share, resulting in proceeds of $942,933. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.1K

5.28% 3M change

40.5% 12M change

Total Value Held $553,075

Neha Krishnamohan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 13 2025	SELL Open market or private sale	$942,933 $23.28 p/Share	40,504 Reduced 64.67%	22,123 Common Stock
Nov 13 2025	BUY Exercise of conversion of derivative security	$316,925 $8.07 p/Share	39,272 Added 38.54%	62,627 Common Stock
Jun 12 2025	BUY Grant, award, or other acquisition	-	7,609 Added 24.57%	23,355 Common Stock
Jun 14 2024	BUY Grant, award, or other acquisition	-	10,139 Added 39.17%	15,746 Common Stock
May 31 2023	BUY Grant, award, or other acquisition	-	4,375 Added 43.83%	5,607 Common Stock

Also insider at

KNTE

Kinnate Biopharma Inc. Healthcare

CHIEF FINANCIAL OFFICER

RTVA

Artiva Biotherapeutics, Inc.

Chief Financial Officer